Market Research Future - Premium Research Reports Small Molecule API Market Analysis 2027 | Page 2

Market Highlights The Global Small Molecule API Market has been evaluated as growing market and expected that the market will reach high growth figures. Small-molecule drugs accounted for 84% of pharmaceutical industry revenues in 2014. In addition, small-molecule drugs still account for approximately two-thirds of the candidates in the current pharmaceutical industry. There has been a significant development in the small molecule API manufacturing in the segments such as oncology, cardiovascular diseases, and metabolic disorders. Besides that, Contract manufacturers that focus on the development and production of small-molecule APIs are experiencing significant growth as a result. The revenues of publicly traded contract manufacturing organizations (CMOs) that are involved only in the development and production of small-molecule drugs increased by 15% in the first half of 2015, with some companies achieving revenue growth of greater than 20%. Key Vendors in the Market are:  Albemarle Corporation  Allergan Plc  Aurobindo Pharma  Cambrex Corporation  Dr. Reddy’s Laboratories Ltd  Glaxosmithkline Plc  Merck Sharp & Dohme Corp.  Mylan N.V.  Novartis AG  Pfizer Inc.  Sun Pharmaceutical Industries Ltd.  Siegfried AG  Teva Pharmaceutical Industries Ltd Tel: [phone] [email protected]